News
WILMINGTON, Del., November 25, 2024--Positive high-level results from the CAPItello-281 Phase III trial showed that AstraZeneca’s TRUQAP® (capivasertib) in combination with abiraterone and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback